Notis-McConarty Edward

Position in LLY — ELI LILLY & Co

CIK 1592616 BOSTON, MA

Position in LLY

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$5,505,382

+$1,769,279 QoQ

Shares Held

4,590

+13.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

2.46%

of 13F equity value

Holder Rank

#1,643

of 4,605 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 57% Shared 43% None 0%

Healthcare · as of Jun 30, 2026

Notis-McConarty Edward holds $20,349,383 across 6 Drug Manufacturers - General names. LLY ranks #2 (27.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	30,391	$7,718,401
2	LLY	ELI LILLY & Co This page	4,590	$5,505,382
3	ABBV	AbbVie Inc.	14,837	$3,733,582
4	AMGN	Amgen Inc	3,986	$1,443,409
5	MRK	Merck & Co., Inc.	10,150	$1,304,275
6	GILD	Gilead Sciences, Inc.	5,100	$644,334

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,505,382	4,590	+13.0%	Shares	Sole	2026-08-11
2026-03-31	$3,736,103	4,062	+17.3%	Shares	Sole	2026-05-08
2025-12-31	$3,722,689	3,464	+43.0%	Shares	Sole	2026-02-17
2025-09-30	$1,848,749	2,423	+41.5%	Shares	Sole	2025-11-10
2025-06-30	$1,334,553	1,712	+494.4%	Shares	Sole	2025-07-23
2025-03-31	$237,860	288	-17.5%	Shares	Sole	2025-05-06
2024-03-31	$271,507	349	-17.7%	Shares	Sole	2024-04-29
2023-12-31	$247,157	424	-8.8%	Shares	Sole	2024-02-14
2023-09-30	$249,765	465	-2.1%	Shares	Sole	2023-11-14
2023-06-30	$222,765	475	-13.6%	Shares	Sole	2023-08-14
2022-12-31	$201,212	550	-11.3%	Shares	Sole	2023-02-09
2022-09-30	$200,477	620	-7.5%	Shares	Sole	2022-11-08
2022-06-30	$217,233	670	-8.2%	Shares	Sole	2022-07-19
2022-03-31	$209,049	730	0.0%	Shares	Sole	2022-05-17
2021-12-31	$201,640	730	—	Shares	Sole	2022-02-08
No filing history on record for this holder in this stock.